Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B1 | P15538 | 3/20 | 0.33 |
| ▸ | CYP11B2 | P19099 | 3/20 | 0.33 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.33 |
| ▸ | IP6K1 | Q92551 | 1/20 | 0.32 |
| ▸ | IP6K3 | Q96PC2 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2627005 | 0.83 | CYP11B1 (0.34) | CYP11B1CYP11B2IP6K1IP6K3 | |
| SCHEMBL25736312 | 0.81 | CYP11B1 (0.41) | CYP11B1CYP11B2CYP19A1IP6K1IP6K3 | |
| SCHEMBL2626986 | 0.80 | CYP11B2 (0.51) | CYP11B1CYP11B2CYP19A1IP6K1IP6K3 | |
| SCHEMBL7090598 | 0.79 | CYP11B2 (0.50) | CYP11B1CYP11B2CYP19A1 | |
| SCHEMBL2627018 | 0.79 | ALDH1A1 (0.32) | CYP11B1CYP11B2CYP19A1 | |
| SCHEMBL2627027 | 0.78 | CYP11B1 (0.38) | CYP11B1CYP11B2CYP19A1IP6K1IP6K3 | |
| SCHEMBL2626975 | 0.77 | CYP11B1 (0.43) | CYP11B1CYP11B2CYP19A1IP6K1IP6K3 | |
| SCHEMBL2627026 | 0.76 | CYP11B1 (0.46) | CYP11B1CYP11B2CYP19A1IP6K1IP6K3 | |
| SCHEMBL25736341 | 0.75 | IP6K1 (0.41) | CYP11B1CYP11B2IP6K1IP6K3 | |
| SCHEMBL21776765 | 0.74 | PTGS2 (0.41) | CYP11B1CYP11B2CYP19A1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8164251-B2 | Aromatic amine derivatives and organic electroluminescence devices using the same | IDEMITSU KOSAN CO., LTD. (JP) | 2012-04-24 | — | — | US | disclosed |
| US-8164251-B2 | Aromatic amine derivatives and organic electroluminescence devices using the same | IDEMITSU KOSAN CO., LTD. (JP) | 2012-04-24 | — | — | US | disclosed |
| US-20090085468-A1 | AROMATIC AMINE DERIVATIVES AND ORGANIC ELECTROLUMINESCENCE DEVICES USING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2009-04-02 | — | — | US | disclosed |
| US-20090085468-A1 | AROMATIC AMINE DERIVATIVES AND ORGANIC ELECTROLUMINESCENCE DEVICES USING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2009-04-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090085468-A1 | AROMATIC AMINE DERIVATIVES AND ORGANIC ELECTROLUMINESCENCE DEVICES USING THE SAME | TYR, EML4, MAOA | CYP11B1 2926/4885CYP11B2 2449/4885CYP19A1 1510/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.